Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of 3 New 6:2 Influenza Virus Reassortants in Adults
NCT01579916Phase 4Completed
- Sponsor
- MedImmune
- Start
- May 2012
- Primary completion
- Nov 2012
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal) in influenza, sponsored by MedImmune. Started May 2012; status: completed.
02
Drugs
influenza vaccine (trivalent, inactivated) or influenza vaccine (live, attenuated, intranasal)
03
Conditions
influenza
Beyond the preview
Go deeper on NCT01579916.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01579916.